RB constrains lineage fidelity and multiple stages of tumour progression and metastasis

Mutations in the Retinoblastoma (RB) tumour suppressor pathway are a hallmark of cancer and a prevalent feature of lung adenocarcinoma(1,2,3). Despite being the first tumour suppressor to be identified, the molecular and cellular basis underlying selection for persistent RB loss in cancer remains un...

Descripción completa

Detalles Bibliográficos
Autores principales: Walter, David M., Yates, Travis J., Ruiz-Torres, Miguel, Kim-Kiselak, Caroline, Gudiel, A. Andrea, Deshpande, Charuhas, Wang, Walter Z., Cicchini, Michelle, Stokes, Kate L., Tobias, John W., Buza, Elizabeth, Feldser, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522292/
https://www.ncbi.nlm.nih.gov/pubmed/31043741
http://dx.doi.org/10.1038/s41586-019-1172-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522292/
https://www.ncbi.nlm.nih.gov/pubmed/31043741
http://dx.doi.org/10.1038/s41586-019-1172-9

Ejemplares similares